Communication from the AGSM of Brighter AB.

Brighter’s Annual General Shareholders Meeting was held on Friday June 9, 2017 at the company’s office in Stockholm, Kista.

Income statements and balance sheets were established and decisions were taken unanimously on disposals of income according to the balance sheet as determined in accordance with the annual report.

The AGSM granted unanimous discharge to board members and CEO.

The AGSM resolved unanimously also to retain the former board and auditor and that compensation for them should be paid according to the proposal in the notice.

The AGSM resolved unanimously to amend the Articles of Association in accordance with Option 3 of the Notice.

The meeting unanimously decided also to give the Board authorization to issue shares in accordance with the summons.

The AGSM resolved unanimously also to approve the proposed instructions for the nomination committee.

The AGSM also resolved to instruct the board to return with improved options programs for board, staff and key resources.

For more information, please contact:
Truls Sjöstedt, CEO              
Tel: +46 709 73 46 00              

Henrik Norström, COO              
Tel: +46 733 40 30 45              

About Brighter AB (publ)  
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 – 454 32 50,,

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 20:15 CEST on June 9 2017.

About Us

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 00,,


Documents & Links